Alteri, Claudia
Fabeni, Lavinia
Scutari, Rossana
Berno, Giulia
Di Carlo, Domenico
Gori, Caterina
Bertoli, Ada
Vergori, Alessandra
Mastrorosa, Ilaria
Bellagamba, Rita
Mussini, Cristina
Colafigli, Manuela
Montella, Francesco
Pennica, Alfredo
Mastroianni, Claudio Maria http://orcid.org/0000-0002-1286-467X
Girardi, Enrico
Andreoni, Massimo
Antinori, Andrea
Svicher, Valentina
Ceccherini-Silberstein, Francesca
Perno, Carlo Federico
Santoro, Maria Mercedes
Article History
Received: 27 June 2018
Accepted: 4 October 2018
First Online: 24 October 2018
Competing Interests
: The authors have no financial and non-financial competing interests that might be perceived to influence the results and/or discussion reported in this paper. However, Francesca Ceccherini-Silberstein reports personal fees from Gilead Sciences, Bristol-Myers Squibb, Abbvie, Roche Diagnostics, Janssen-Cilag, Abbott Molecular, ViiV Healthcare; grants and personal fees from Merck Sharp & Dohme; grants from Italian Ministry of Education, University and Research (MIUR). Carlo Federico Perno reports grants from Italian Ministry of Instruction, University and Research (MIUR), and from Aviralia Foundation; personal fees from Gilead Sciences, Abbvie, Roche Diagnostics, Janssen-Cilag, Abbott Molecular; and grants and personal fees from Bristol-Myers Squibb, Merck Sharp & Dohme, and ViiV Healthcare. All other authors have nothing to declare.